SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 31 8 2021
medline: 14 1 2022
entrez: 30 8 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

pubmed: 34455813
doi: 10.1161/HYPERTENSIONAHA.121.17579
pmc: PMC8415523
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

983-995

Auteurs

Stephane Laurent (S)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).

Gilles Chatellier (G)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
Clinical Research Unit, INSERM U970, Paris (G. Chatellier, H.P.).

Michel Azizi (M)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
Hypertension Department and DMU CARTE, Paris, France (M.A.).
INSERM, CIC1418, Paris, France (M.A.).

David Calvet (D)

Neurology department, GHU Paris Psychiatrie Neurosciences, Sainte-Anne Hospital (D.C.).
INSERM UMR 1266, FHU NeuroVasc, Paris, France (D.C.).

Gabriel Choukroun (G)

Nephrology Dialysis Transplantation Department, CHU Amiens, France (G. Choukroun).
MP3CV Research Unit, University Picardie Jules Verne, France (G. Choukroun).

Nicolas Danchin (N)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
Cardiology Department, Georges Pompidou Hospital, Paris, France (N.D.).

Pascal Delsart (P)

CHU Lille, Institut Cœur Poumon, Lille, France (P.D.).

Xavier Girerd (X)

ICAN, Sorbonne University, Assistance-Publique Hopitaux de Paris, Paris, France (X.G.).

Philippe Gosse (P)

Cardiology Department, Saint Andre Hospital, CHU Bordeaux, France (P.G.).

Hakim Khettab (H)

Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
INSERM U970, Cardiovascular Research Center - PARCC, Paris, France (H.K., R.-M.B., P.B.).

Gerard London (G)

Department of Nephrology, Manhes Hospital, Fleury Merogis, France(G.L.).

Jean-Jacques Mourad (JJ)

Paris Saint-Joseph Hospital, Paris, France (J.-J.M.).

Bruno Pannier (B)

Department of Internal Medicine, Manhes Hospital, Fleury Merogis, France (B.P.).

Helena Pereira (H)

Clinical Research Unit, INSERM U970, Paris (G. Chatellier, H.P.).

Dominique Stephan (D)

University of Strasbourg, France (D.S.).
UMR 1260, INSERM-University of Strasbourg, France (D.S.).

Paul Valensi (P)

Unit of Endocrinology-Diabetology-Nutrition, Assistance-Publique Hopitaux de Paris, Jean Verdier Hospital, University Sorbonne Paris Cite, Bondy, France (P.V.).

Pedro Cunha (P)

Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk, Internal Medicine Department, Guimaraes, Portugal (P.C.).
Life and Health Research Institute (ICVS/3B's), Minho University, Portugal (P.C.).

Krzysztof Narkiewicz (K)

Department of Hypertension and Diabetology, Faculty of Medicine, Medical University of Gdansk, Debinki, Gdansk, Poland (K.N.).

Rosa-Maria Bruno (RM)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
INSERM U970, Cardiovascular Research Center - PARCC, Paris, France (H.K., R.-M.B., P.B.).

Pierre Boutouyrie (P)

From the Université de Paris, France (S.L., G. Chatellier, M.A., N.D., R.-M.B., P.B.).
Assistance-Publique Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France (S.L., G. Chatellier, M.A., N.D., H.K., R.-M.B., P.B.).
INSERM U970, Cardiovascular Research Center - PARCC, Paris, France (H.K., R.-M.B., P.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH